doi:10.1016/0167-0115(94)90136-8 8
Do not freeze the medication
Weight Loss: The Default Job The pivotal obesity trial enrolled about 1,960 non-diabetic adults with a mean weight of 105 kg, BMI of 38, average age of 46, and a cohort that was roughly three-quarters women
J Exp Biol (2017) 220(Pt 9):1693700
BPC-157 This peptide is derived from a naturally occurring stomach protein and is widely researched for its role in healing soft tissue, supporting gut integrity, improving blood flow, reducing inflammation, and promoting the development of new blood vessels
Metabolic Health & Anti-Inflammatory Benefits Dosage: 35 mg per week (SC or IV) Cycle: 4-week cycle, repeated every 612 months Administration: Best taken while following a low-inflammatory diet (paleo, keto, or fasting protocols) Stacking: With Berberine or AICAR for metabolic regulation With Thymosin Alpha-1 (TA-1) for immune modulation Expected Benefits: Reduced chronic inflammation and oxidative stress Improved insulin sensitivity and glucose metabolism Enhanced mitochondrial function and energy levels Further reading FOXO4-DRI belongs to a class of compounds known as senolytics, which are designed to target and remove senescent cells